<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01//EN"
                      "http://www.w3.org/TR/html4/strict.dtd">
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="generator" content="hypermail 2.1.5, see http://www.hypermail.org/">
<title>Extropians: Re: HEALTH: Caffeinol limits stroke damage</title>
<meta name="Author" content="Anders Sandberg (asa@nada.kth.se)">
<meta name="Subject" content="Re: HEALTH: Caffeinol limits stroke damage">
<meta name="Date" content="2003-04-11">
<style type="text/css">
body {color: black; background: #ffffff}
h1.center {text-align: center}
div.center {text-align: center}
</style>
</head>
<body>
<h1>Re: HEALTH: Caffeinol limits stroke damage</h1>
<!-- received="Fri Apr 11 11:30:26 2003" -->
<!-- isoreceived="20030411173026" -->
<!-- sent="Fri, 11 Apr 2003 19:34:13 +0200" -->
<!-- isosent="20030411173413" -->
<!-- name="Anders Sandberg" -->
<!-- email="asa@nada.kth.se" -->
<!-- subject="Re: HEALTH: Caffeinol limits stroke damage" -->
<!-- id="20030411173412.GA14120@akira.nada.kth.se" -->
<!-- charset="us-ascii" -->
<!-- inreplyto="Pine.LNX.4.44.0304110728230.10002-100000@server.aeiveos.com" -->
<!-- expires="-1" -->
<p>
<strong>From:</strong> Anders Sandberg (<a href="mailto:asa@nada.kth.se?Subject=Re:%20HEALTH:%20Caffeinol%20limits%20stroke%20damage"><em>asa@nada.kth.se</em></a>)<br>
<strong>Date:</strong> Fri Apr 11 2003 - 11:34:13 MDT
</p>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="6189.html">Samantha Atkins: "Re: IRAQ: Predictable catastrophes of human stupidity"</a>
<ul>
<li><strong>Previous message:</strong> <a href="6187.html">matus: "RE: Help with a Minimum Wage Model"</a>
<li><strong>In reply to:</strong> <a href="6176.html">Robert J. Bradbury: "HEALTH: Caffeinol limits stroke damage"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="6235.html">Harvey Newstrom: "RE: HEALTH: Caffeinol limits stroke damage"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#6188">[ date ]</a>
<a href="index.html#6188">[ thread ]</a>
<a href="subject.html#6188">[ subject ]</a>
<a href="author.html#6188">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<hr>
<!-- body="start" -->
<p>
On Fri, Apr 11, 2003 at 07:39:32AM -0700, Robert J. Bradbury wrote:
<br>
<em>&gt; 
</em><br>
<em>&gt; Science Daily is reporting on a study where caffeinol --
</em><br>
<em>&gt; a mixture of caffeine and ethanol may be able to
</em><br>
<em>&gt; limit damage caused by ischemic strokes.
</em><br>
<p>It is fun to see that it has approached clinical use. I posted about 
<br>
this a few years ago, when it was just animal experiments. Things have 
<br>
moved a bit since then:
<br>
<p><a href="http://www.neurologyreviews.com/jan00/nr_jan00_alcoholcaffeine.html">http://www.neurologyreviews.com/jan00/nr_jan00_alcoholcaffeine.html</a>
<br>
<p><em>&gt; I'm kind of blown away because I can't even begin to
</em><br>
<em>&gt; imagine how this works at the molecular level.
</em><br>
<p>Caffeine affects adenosine receptors, and that is likely important for 
<br>
reducing glutamate toxicity. Ethanol does strange things to cell 
<br>
membrances and receptors. 
<br>
<p>As Doug mentioned (I think this was the one I got too):
<br>
<p>Title
<br>
&nbsp;&nbsp;Combination of low dose
<br>
&nbsp;&nbsp;ethanol and caffeine protects brain from damage produced by
<br>
&nbsp;&nbsp;focal ischemia in rats.
<br>
Source
<br>
&nbsp;&nbsp;Neuropharmacology.  39(3):515-22, 2000 Jan 28.
<br>
Abstract
<br>
&nbsp;&nbsp;Caffeine and ethanol are two commonly overused psychoactive
<br>
&nbsp;&nbsp;dietary components. The purpose of this study was to assess the 
<br>
effects of
<br>
&nbsp;&nbsp;acute, chronic, oral (p.o.) and intravenous (i.v.) caffeine,
<br>
&nbsp;&nbsp;ethanol and their combination on infarct
<br>
&nbsp;&nbsp;volume following focal ischemia in rats. Rats received
<br>
&nbsp;&nbsp;treatment either p.o. 3 h and 1 h before, or by i.v. infusion for 2.5 
<br>
h
<br>
&nbsp;&nbsp;beginning 30-180 min after, ischemia. There were six acute treatment 
<br>
groups.
<br>
&nbsp;&nbsp;(1) oral dH2O (control); (2) oral caffeine (10 mg/kg); (3) oral
<br>
&nbsp;&nbsp;ethanol (0.65 g/kg total); (4) oral ethanol
<br>
&nbsp;&nbsp;plus caffeine; (5) intravenous saline; and (6) intravenous
<br>
&nbsp;&nbsp;ethanol (0.65 g/kg) plus caffeine (10 mg/kg) in saline. A
<br>
&nbsp;&nbsp;7th group received oral ethanol plus caffeine for three
<br>
&nbsp;&nbsp;weeks prior to ischemia. After 3 h of left MCA/CCA occlusion and 24 h
<br>
&nbsp;&nbsp;reperfusion, infarct volume was determined. Control animal infarct 
<br>
volume was
<br>
&nbsp;&nbsp;102.4+/-42.0 mm3. Oral caffeine alone had no effect (122.4+/-30.2 
<br>
mm3). Oral
<br>
&nbsp;&nbsp;ethanol alone exacerbated infarct volume (177.2+/-27.8 mm3).
<br>
&nbsp;&nbsp;Oral caffeine plus ethanol almost entirely eliminated the
<br>
&nbsp;&nbsp;damage (17.89+/-10.41 mm3). When i.v. treatment with ethanol
<br>
&nbsp;&nbsp;plus caffeine was initiated at 30, 60, 90 and 120 minutes 
<br>
post-ischemia the
<br>
&nbsp;&nbsp;infarct volume was reduced by 71.7%, 49.8%, 64.8% and 47.1%, 
<br>
respectively.
<br>
&nbsp;&nbsp;Chronic daily oral ethanol plus caffeine prior to ischemia
<br>
&nbsp;&nbsp;eliminated the neuroprotection seen with acute treatment. These 
<br>
studies
<br>
&nbsp;&nbsp;indicate that ethanol, which by itself aggravates cerebral
<br>
&nbsp;&nbsp;ischemia, and caffeine, when combined together immediately before or 
<br>
for 2 h
<br>
&nbsp;&nbsp;after focal stroke, reduces ischemic damage.
<br>
<p><p><pre>
-- 
-----------------------------------------------------------------------
Anders Sandberg                                      Towards Ascension!
<a href="mailto:asa@nada.kth.se?Subject=Re:%20HEALTH:%20Caffeinol%20limits%20stroke%20damage">asa@nada.kth.se</a>                            <a href="http://www.nada.kth.se/~asa/">http://www.nada.kth.se/~asa/</a>
GCS/M/S/O d++ -p+ c++++ !l u+ e++ m++ s+/+ n--- h+/* f+ g+ w++ t+ r+ !y
</pre>
<!-- body="end" -->
<hr>
<ul>
<!-- next="start" -->
<li><strong>Next message:</strong> <a href="6189.html">Samantha Atkins: "Re: IRAQ: Predictable catastrophes of human stupidity"</a>
<li><strong>Previous message:</strong> <a href="6187.html">matus: "RE: Help with a Minimum Wage Model"</a>
<li><strong>In reply to:</strong> <a href="6176.html">Robert J. Bradbury: "HEALTH: Caffeinol limits stroke damage"</a>
<!-- nextthread="start" -->
<li><strong>Next in thread:</strong> <a href="6235.html">Harvey Newstrom: "RE: HEALTH: Caffeinol limits stroke damage"</a>
<!-- reply="end" -->
<li><strong>Messages sorted by:</strong> 
<a href="date.html#6188">[ date ]</a>
<a href="index.html#6188">[ thread ]</a>
<a href="subject.html#6188">[ subject ]</a>
<a href="author.html#6188">[ author ]</a>
<a href="attachment.html">[ attachment ]</a>
</ul>
<!-- trailer="footer" -->
<hr>
<p><small><em>
This archive was generated by <a href="http://www.hypermail.org/">hypermail 2.1.5</a> 
: Fri Apr 11 2003 - 11:39:00 MDT
</em></small></p>
</body>
</html>
